Reljić R, Cosentino G, Gould H J
Developmental Biology Research Center, The Randall Institute, King's College, London, GB.
Eur J Immunol. 1997 Feb;27(2):572-5. doi: 10.1002/eji.1830270232.
Co-ligation of antigen receptor and complement receptor 2 (CD21) in the B cell membrane is important in the immune response to T-dependent antigens. Four CD21 ligands have so far been identified, but only the activated products of the third component of complement (C3) are known to augment the immune response to specific antigens. The most recently discovered ligand for CD21 is CD23. We have generated a CD32+ CD23+ fibroblast cell line which presents a surrogate antigen (anti-IgM) to human tonsil B cells in vitro. Incubation with these cells causes a 10- to 100-fold reduction in the threshold concentration of anti-IgM required for B cell proliferation. Anti-CD19 further enhances the response to antigen and induces proliferation in the absence of anti-IgM. Addition of soluble CD21 totally inhibits the effect of CD23, suggesting that CD21 mediates synergistic signaling by CD23.
B细胞膜中抗原受体与补体受体2(CD21)的共连接在对T细胞依赖性抗原的免疫反应中很重要。迄今为止已鉴定出四种CD21配体,但已知只有补体第三成分(C3)的活化产物能增强对特定抗原的免疫反应。CD21最近发现的配体是CD23。我们已建立了一种CD32 + CD23 +成纤维细胞系,该细胞系在体外向人扁桃体B细胞呈递替代抗原(抗IgM)。与这些细胞孵育会使B细胞增殖所需的抗IgM阈值浓度降低10至100倍。抗CD19进一步增强对抗原的反应,并在没有抗IgM的情况下诱导增殖。添加可溶性CD21完全抑制CD23的作用,表明CD21介导CD23的协同信号传导。